Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisJulian D. Gillmore, Philip N. Hawkins, Giovanni Palladini et al.|Circulation|2016Cited by 2k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisMorie A. Gertz, G Grateau, Ray Comenzo et al.|American Journal of Hematology|2005Cited by 1.4k
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year StudyMartha Skinner, Daniel G. Wright, Vaishali Sanchorawala et al.|Annals of Internal Medicine|2004Cited by 615
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosisRaymond L. Comenzo, Giampaolo Merlini, Donna Reece et al.|Leukemia|2012Cited by 383
Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine onlyMartha Skinner, Alan S. Cohen, Jennifer J. Anderson et al.|The American Journal of Medicine|1996Cited by 372